359 related articles for article (PubMed ID: 32619678)
1. Serotonin and noradrenaline modulate chronic itch processing in mice.
Miyahara Y; Funahashi H; Naono-Nakayama R; Haruta-Tsukamoto A; Muroi C; Kogoh Y; Nishimori T; Ishida Y
Eur J Pharmacol; 2020 Sep; 883():173319. PubMed ID: 32619678
[TBL] [Abstract][Full Text] [Related]
2. Role of serotonin and noradrenaline in the acute itch processing in mice.
Miyahara Y; Funahashi H; Naono-Nakayama R; Haruta-Tsukamoto A; Nishimori T; Ishida Y
Eur J Pharmacol; 2019 May; 850():118-125. PubMed ID: 30763572
[TBL] [Abstract][Full Text] [Related]
3. Acute effect of milnacipran on the relationship between the locus coeruleus noradrenergic and dorsal raphe serotonergic neuronal transmitters.
Bandoh T; Hayashi M; Ino K; Takada S; Ushizawa D; Hoshi K
Eur Neuropsychopharmacol; 2004 Dec; 14(6):471-8. PubMed ID: 15589386
[TBL] [Abstract][Full Text] [Related]
4. Milnacipran inhibits itch-related responses in mice through the enhancement of noradrenergic transmission in the spinal cord.
Andoh T; Gotoh Y; Kuraishi Y
J Pharmacol Sci; 2013; 123(2):199-202. PubMed ID: 24096836
[TBL] [Abstract][Full Text] [Related]
5. Roles of 5-HT
Miyahara Y; Funahashi H; Haruta-Tsukamoto A; Kogoh Y; Kanemaru-Kawazoe A; Nishimori T; Ishida Y
Eur J Pharmacol; 2021 Nov; 911():174513. PubMed ID: 34555396
[TBL] [Abstract][Full Text] [Related]
6. The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine.
Montezinho LP; Miller S; Plath N; Jensen NH; Karlsson JJ; Witten L; Mørk A
Psychopharmacology (Berl); 2010 Oct; 212(2):131-43. PubMed ID: 20676614
[TBL] [Abstract][Full Text] [Related]
7. Differential Contribution of 5-HT
Miyahara Y; Funahashi H; Haruta-Tsukamoto A; Kogoh Y; Kanemaru-Kawazoe A; Hirano Y; Nishimori T; Ishida Y
Biol Pharm Bull; 2023 Nov; 46(11):1601-1608. PubMed ID: 37722878
[TBL] [Abstract][Full Text] [Related]
8. Serotonin and noradrenaline reuptake inhibitors in animal models of pain.
Mochizucki D
Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S15-9. PubMed ID: 15378668
[TBL] [Abstract][Full Text] [Related]
9. 5-HT3 receptors antagonists reduce serotonin-induced scratching in mice.
Ostadhadi S; Kordjazy N; Haj-Mirzaian A; Mansouri P; Dehpour AR
Fundam Clin Pharmacol; 2015 Jun; 29(3):310-5. PubMed ID: 25711853
[TBL] [Abstract][Full Text] [Related]
10. Chronic effects of antidepressants on serotonin release in rat raphe slice cultures: high potency of milnacipran in the augmentation of serotonin release.
Nagayasu K; Kitaichi M; Nishitani N; Asaoka N; Shirakawa H; Nakagawa T; Kaneko S
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2295-306. PubMed ID: 23920436
[TBL] [Abstract][Full Text] [Related]
11. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N
Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.
Yamada J; Sugimoto Y
Brain Res; 2002 Dec; 958(1):161-5. PubMed ID: 12468041
[TBL] [Abstract][Full Text] [Related]
13. Preclinical pharmacology of milnacipran.
Briley M; Prost JF; Moret C
Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():9-14. PubMed ID: 8923122
[TBL] [Abstract][Full Text] [Related]
14. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.
Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
Neuroscience; 1999; 93(4):1251-62. PubMed ID: 10501449
[TBL] [Abstract][Full Text] [Related]
15. Clonidine inhibits itch-related response through stimulation of α(2)-adrenoceptors in the spinal cord in mice.
Gotoh Y; Andoh T; Kuraishi Y
Eur J Pharmacol; 2011 Jan; 650(1):215-9. PubMed ID: 20951695
[TBL] [Abstract][Full Text] [Related]
16. Milnacipran, a serotonin and noradrenaline reuptake inhibitor, suppresses long-term potentiation in the rat hippocampal CA1 field via 5-HT1A receptors and alpha 1-adrenoceptors.
Tachibana K; Matsumoto M; Togashi H; Kojima T; Morimoto Y; Kemmotsu O; Yoshioka M
Neurosci Lett; 2004 Mar; 357(2):91-4. PubMed ID: 15036582
[TBL] [Abstract][Full Text] [Related]
17. The monoamine-mediated antiallodynic effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a rat model of neuropathic pain.
Obata H; Saito S; Koizuka S; Nishikawa K; Goto F
Anesth Analg; 2005 May; 100(5):1406-1410. PubMed ID: 15845695
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex.
Felton TM; Kang TB; Hjorth S; Auerbach SB
Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):297-305. PubMed ID: 12644903
[TBL] [Abstract][Full Text] [Related]
19. Effects of the serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran on marble burying behavior in mice.
Sugimoto Y; Tagawa N; Kobayashi Y; Hotta Y; Yamada J
Biol Pharm Bull; 2007 Dec; 30(12):2399-401. PubMed ID: 18057733
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic-like effect of milnacipran in the four-plate test in mice: mechanism of action.
Bourin M; Masse F; Dailly E; Hascoët M
Pharmacol Biochem Behav; 2005 Jul; 81(3):645-56. PubMed ID: 15961146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
